Report Detail

Pharma & Healthcare Global (United States, European Union and China) Parkinsons disease Drug Market Research Report 2019-2025

  • RnM3663521
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease.
In 2019, the market size of Parkinsons disease Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Parkinsons disease Drug.

This report studies the global market size of Parkinsons disease Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Parkinsons disease Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia

Market Segment by Product Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors

Market Segment by Application
Hospital
Online
Retail Pharmacies

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Parkinsons disease Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Parkinsons disease Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Parkinsons disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Parkinsons disease Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Carbidopa/Levodopa
      • 1.3.3 Dopamine Receptor Agonists
      • 1.3.4 MAO-Inhibitors
    • 1.4 Market Segment by Application
      • 1.4.1 Global Parkinsons disease Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Online
      • 1.4.4 Retail Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Parkinsons disease Drug Market Size
      • 2.1.1 Global Parkinsons disease Drug Revenue 2014-2025
      • 2.1.2 Global Parkinsons disease Drug Sales 2014-2025
    • 2.2 Parkinsons disease Drug Growth Rate by Regions
      • 2.2.1 Global Parkinsons disease Drug Sales by Regions 2014-2019
      • 2.2.2 Global Parkinsons disease Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Parkinsons disease Drug Sales by Manufacturers
      • 3.1.1 Parkinsons disease Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Parkinsons disease Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Parkinsons disease Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Parkinsons disease Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Parkinsons disease Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Parkinsons disease Drug Price by Manufacturers
    • 3.4 Key Manufacturers Parkinsons disease Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Parkinsons disease Drug Market
    • 3.6 Key Manufacturers Parkinsons disease Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Carbidopa/Levodopa Sales and Revenue (2014-2019)
      • 4.1.2 Dopamine Receptor Agonists Sales and Revenue (2014-2019)
      • 4.1.3 MAO-Inhibitors Sales and Revenue (2014-2019)
    • 4.2 Global Parkinsons disease Drug Sales Market Share by Type
    • 4.3 Global Parkinsons disease Drug Revenue Market Share by Type
    • 4.4 Parkinsons disease Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Parkinsons disease Drug Sales by Application

    6 United States

    • 6.1 United States Parkinsons disease Drug Breakdown Data by Company
    • 6.2 United States Parkinsons disease Drug Breakdown Data by Type
    • 6.3 United States Parkinsons disease Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Parkinsons disease Drug Breakdown Data by Company
    • 7.2 European Union Parkinsons disease Drug Breakdown Data by Type
    • 7.3 European Union Parkinsons disease Drug Breakdown Data by Application

    8 China

    • 8.1 China Parkinsons disease Drug Breakdown Data by Company
    • 8.2 China Parkinsons disease Drug Breakdown Data by Type
    • 8.3 China Parkinsons disease Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Parkinsons disease Drug Breakdown Data by Company
    • 9.2 Rest of World Parkinsons disease Drug Breakdown Data by Type
    • 9.3 Rest of World Parkinsons disease Drug Breakdown Data by Application
    • 9.4 Rest of World Parkinsons disease Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Parkinsons disease Drug Sales by Countries
      • 9.4.2 Rest of World Parkinsons disease Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Teva
      • 10.1.1 Teva Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.1.4 Parkinsons disease Drug Product Introduction
      • 10.1.5 Teva Recent Development
    • 10.2 Novartis AG
      • 10.2.1 Novartis AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.2.4 Parkinsons disease Drug Product Introduction
      • 10.2.5 Novartis AG Recent Development
    • 10.3 GSK
      • 10.3.1 GSK Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.3.4 Parkinsons disease Drug Product Introduction
      • 10.3.5 GSK Recent Development
    • 10.4 AbbVie
      • 10.4.1 AbbVie Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.4.4 Parkinsons disease Drug Product Introduction
      • 10.4.5 AbbVie Recent Development
    • 10.5 Merck
      • 10.5.1 Merck Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.5.4 Parkinsons disease Drug Product Introduction
      • 10.5.5 Merck Recent Development
    • 10.6 Boehringer Ingelheim
      • 10.6.1 Boehringer Ingelheim Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.6.4 Parkinsons disease Drug Product Introduction
      • 10.6.5 Boehringer Ingelheim Recent Development
    • 10.7 Impax Laboratories
      • 10.7.1 Impax Laboratories Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.7.4 Parkinsons disease Drug Product Introduction
      • 10.7.5 Impax Laboratories Recent Development
    • 10.8 Lundbeck
      • 10.8.1 Lundbeck Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.8.4 Parkinsons disease Drug Product Introduction
      • 10.8.5 Lundbeck Recent Development
    • 10.9 Sun Pharma
      • 10.9.1 Sun Pharma Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.9.4 Parkinsons disease Drug Product Introduction
      • 10.9.5 Sun Pharma Recent Development
    • 10.10 Wockhardt
      • 10.10.1 Wockhardt Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Parkinsons disease Drug
      • 10.10.4 Parkinsons disease Drug Product Introduction
      • 10.10.5 Wockhardt Recent Development
    • 10.11 UCB
    • 10.12 Valeant Pharmaceuticals
    • 10.13 Acadia

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Parkinsons disease Drug Sales Channels
      • 11.2.2 Parkinsons disease Drug Distributors
    • 11.3 Parkinsons disease Drug Customers

    12 Market Forecast

    • 12.1 Global Parkinsons disease Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Parkinsons disease Drug Sales Forecast by Type
    • 12.3 Global Parkinsons disease Drug Sales Forecast by Application
    • 12.4 Parkinsons disease Drug Forecast by Regions
      • 12.4.1 Global Parkinsons disease Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Parkinsons disease Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Parkinsons disease Drug. Industry analysis & Market Report on Parkinsons disease Drug is a syndicated market report, published as Global (United States, European Union and China) Parkinsons disease Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Parkinsons disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,624.00
      3,936.00
      5,248.00
      3,063.52
      4,595.28
      6,127.04
      516,042.40
      774,063.60
      1,032,084.80
      273,519.20
      410,278.80
      547,038.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report